title: Overview of the clinical trials on bioresorbable vascular scaffold.
abstract: Although several new scaffolds are progressively being investigated and entering the clinical scene, BRS has accumulated the largest experience by far including detailed evaluation of the first patients studied followed almost in parallel by clinical evaluation and worldwide randomized evaluation for non-inferiority against best contemporary metallic DES. Available evidence shows that careful procedural technique is required for proper and safe delivery of the current generation scaffolds. Future studies will indicate whether all or only selected patient or lesion subsets will ultimately benefit from treatment with fully bioresorbable devices.
authors.affiliation: Cardiovascular Research Center Aalst, OLV Hospital, Aalst, Belgium - emanuele.barbato@olvz-aalst.be.
authors.forename: Angela
authors.initials: A
authors.lastname: Ferrara
authors.forename: Giuseppe
authors.initials: G
authors.lastname: DI Gioia
authors.forename: Teresa
authors.initials: T
authors.lastname: Strisciuglio
authors.forename: William
authors.initials: W
authors.lastname: Wijns
authors.forename: Emanuele
authors.initials: E
authors.lastname: Barbato
mesh_terms: D020341:Absorbable Implants / Q000009:adverse effects; D001807:Blood Vessel Prosthesis / Q000009:adverse effects; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000379:methods*; D002986:Clinical Trials as Topic; D054855:Drug-Eluting Stents; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D054457:Tissue Scaffolds / Q000009:adverse effects